Summary & Overview
HCPCS J2540: Penicillin G Potassium Injection, Up to 600,000 Units
HCPCS Level II code J2540 denotes the injectable antibiotic penicillin G potassium, dosed up to 600,000 units. This code identifies a commonly used parenteral treatment for susceptible bacterial infections and matters nationally because it affects drug administration billing across outpatient clinics, emergency departments, and inpatient settings. Accurate use of the code supports appropriate claims processing and reporting of antibiotic utilization.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides a concise overview of billing benchmarks, payer coverage patterns, and clinical context for use of J2540. Readers will learn how the code maps to medication administration services, typical sites of service, and common clinical scenarios in which penicillin G potassium is administered.
The report also highlights where data is available and notes when input fields are not provided. It supplies practical reference information for coding, claims submission, and crosswalks to service lines without offering clinical recommendations. Intended readers include coding professionals, revenue cycle managers, and policy analysts seeking national-level guidance on billing for injectable penicillin G potassium.
Billing Code Overview
HCPCS Level II code J2540 represents an injection of penicillin G potassium, with a dose description of up to 600,000 units. The service is a parenteral antibiotic administration, typically provided as an intramuscular or intravenous injection depending on clinical indication and formulation. The typical site of service for this code is outpatient clinic, emergency department, or inpatient facility when the medication is administered by clinical staff.
Service type: Medication administration (injectable antibiotic)
Typical site of service: Outpatient clinic, emergency department, or inpatient facility
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an outpatient clinic or urgent care with streptococcal pharyngitis, early syphilis, or a documented penicillin-susceptible bacterial infection requiring intramuscular benzathine or aqueous penicillin therapy. The clinician evaluates history, allergies (confirming no immediate-type penicillin allergy), and baseline vitals. The provider selects J2540 for penicillin G potassium up to 600,000 units when preparing an intramuscular or intravenous dose appropriate for the infection and patient weight.
The workflow: the nurse verifies orders and allergy status, prepares the correct concentration and syringe, obtains informed consent for injection, and administers the injection intramuscularly (or intravenously when indicated) using standard infection control. Post-injection observation for anaphylaxis occurs for 15–30 minutes. Documentation includes drug name penicillin G potassium, units administered (per J2540 unit definition), route, site, lot number, and patient response. Billing uses J2540 with appropriate modifiers to indicate status, payer-specific requirements, and any partial dispensing or wastage reporting such as JW if applicable.
Coding Specifications
| Modifier | Description | When to Use |
|---|